Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2012 06:30 ET | Source: Acura Pharmaceuticals

NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production

PALATINE, IL--(Marketwire - Mar 2, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced independent laboratory...
October 17, 2011 06:00 ET | Source: Acura Pharmaceuticals

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer

PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...